Australian Competition and Consumer Commission v Reckitt Benckiser
[2016] FCA 167
At a glance
Source factsCourt
Federal Court of Australia
Decision date
2016-02-29
Before
Mr J, Edelman J
Source
Original judgment source is linked above.
Judgment (7 paragraphs)
- The applicant make any application to amend its fast track statement by 3 March 2016.
- The respondent produce any representative document or documents recording or evidencing: (a) the retail prices; and (b) the recommended retail prices for each of: (c) Nurofen Tablets (all SKUs); (d) Nurofen Caplets (all SKUs); (e) Nurofen Zavance Tablets (all SKUs); and (f) Nurofen Zavance Caplets (all SKUs), in the years 2011 to 2015 inclusive.
- The respondent produce any representative document or documents recording or evidencing: (a) the wholesale list price per case or packet; (b) the wholesale list price per unit or tablet/caplet; and (c) the gross profit margin; for each of: (d) Nurofen Tablets (all SKUs); (e) Nurofen Caplets (all SKUs); (f) Nurofen Zavance Tablets (all SKUs); and (g) Nurofen Zavance Caplets (all SKUs), in the years 2011 to 2015 inclusive.
- Costs of this application be reserved.
- The matter be listed for directions on 4 March 2016 at 10.15am (Brisbane time). Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Introduction 1 The central issue in this interlocutory application is the extent to which the ACCC is required to plead facts upon which it relies in a penalty hearing. The issue arises because the ACCC seeks discovery of many documents by relying upon a basis which is not pleaded. The research of counsel, and my searches, suggests that this pleading issue has not previously arisen in any previous pecuniary penalty case in Australia. The reason why this issue may not have previously arisen is because a pragmatic and cooperative approach to a penalty hearing will usually avoid unproductive pleading disputes. However, in relation to the central issue in this case (although possibly not in others) the matter has real significance to how the penalty hearing will be conducted. 2 On 17 February 2016, following judgment concerning liability, the ACCC brought this application under r 20.15 of the Federal Court Rules 2011 (Cth) for interlocutory orders for discovery relating to the forthcoming penalty hearing. The ACCC seeks documents falling into eight different categories. The documents are sought for various reasons but a central reason for which all the documents in categories 1 to 6 are sought, influencing the basis upon which those categories have been shaped, is to establish the following matters relevant to the determination of the quantum of the penalty to be ordered: the "deliberateness" of the contravention; the conduct as "systematic", "deliberate", or "covert"; and whether Reckitt Benckiser "took the odds" or "courted the risk" of engaging in contravening conduct. Reckitt Benckiser refers to these asserted bases for the application collectively as "intentionality" issues. 3 It is unnecessary to set out the precise terms of the categories of discovery. This is because the primary question in this application is one of basic principle. It is whether discovery should be ordered of documents relevant to these unpleaded "intentionality" issues. The ACCC has filed substantial evidence in support of some of these allegations of intentionality. But until that evidence was filed on this discovery application no such issue arose between the parties. The ACCC essentially submits that discovery should be ordered concerning matters which are not in issue and that Reckitt Benckiser should be denied the opportunity even of making submissions concerning whether the ACCC can amend its case to raise new and extremely serious allegations which had not been alleged prior to, or in the months following, the determination of the proceedings in relation to liability. I reject those submissions by the ACCC. However, I accept the separate submissions by the ACCC that documents in categories 7 and 8 should be discovered.